RxDoctor Payments Data

Douglas Hoy, MD

Family Medicine · Bellevue, OHNPI 1437139755

Payments from drug & device makers

$2,719in general payments, 2019–2025

Across 176 payments — averaging $15.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$702
  • Amgen$229
  • Pfizer$156
  • AstraZeneca$155
  • GSK$134
  • Novo Nordisk$125
  • plus $1K from 29 others

What the payments were for

  • Food & beverage$2,70599%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,719 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$176,266
Medicare patients
546
Services billed
3,848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban346$236,131
JardianceEmpagliflozin175$157,038
OzempicSemaglutide96$103,719
JanuviaSitagliptin Phosphate79$70,320
XareltoRivaroxaban73$57,282
Breo ElliptaFluticasone/Vilanterol98$44,400
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$39,881
XifaxanRifaximin11$37,539
RexultiBrexpiprazole23$33,772
FarxigaDapagliflozin Propanediol53$32,723
LinzessLinaclotide32$26,763
EntrestoSacubitril/Valsartan34$26,131
VraylarCariprazine Hcl15$22,453
MyrbetriqMirabegron22$19,780
Liothyronine Sodium521$19,036

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt, Abrysvo, Premarin$156$267,411426 claims
Boehringer IngelheimJardiance$25$157,038175 claims
Novo NordiskOzempic$125$103,71996 claims
GSKBreo Ellipta, Trelegy Ellipta, Shingrix$134$93,707197 claims
MerckJanuvia$90$70,32079 claims
Johnson & JohnsonXarelto$14$57,28273 claims
AbbVieLinzess, Vraylar$702$49,21647 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$69$37,53911 claims
Otsuka America Pharmaceutical, Inc.Rexulti$69$33,77223 claims
AstraZenecaFarxiga$155$32,72353 claims
Lilly USA, LLCMounjaro, Trulicity$124$30,78529 claims
NovartisEntresto$108$26,13134 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Bellevue

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →